Satellos Bioscience Inc.
Research Satellos Bioscience Inc. (MSCL) on Bullrun: market cap CAD 234.35M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMSCL
- ExchangeTO
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCAD
- Market capCAD 234.35M
- Financial periodQ4 2025
- Net income-CAD 7.30M
- Free cash flow-CAD 7.26M
Valuation Snapshot
latest market cap is CAD 234.35M.
About Satellos Bioscience Inc.
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease.
Frequently asked questions
What is Satellos Bioscience Inc.'s market cap?
Satellos Bioscience Inc.'s market capitalization is CAD 234.35M.
What does Satellos Bioscience Inc. do?
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia.